Pulse Biosciences PLSE
NASDAQ PLSE
$50.42 +2.57 (+5.37%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pulse Biosciences (PLSE) Long-Term Investments (2017)

Pulse Biosciences (PLSE) posted quarterly Long-Term Investments of $4.6 million for Q4 2017.

Pulse Biosciences (PLSE) Long-Term Investments (2017) Analysis & Trends

Pulse Biosciences' Long-Term Investments history runs 1 years deep, the most recent figure standing at $4.6 million for Q4 2017.

  • In Q4 2017, Long-Term Investments changed N/A year-over-year to $4.6 million; the TTM figure through Dec 2017 stood at $4.6 million (changed N/A YoY), while the FY2017 annual figure was $4.6 million, changed N/A from the prior year.
  • Long-Term Investments for Q4 2017 stood at $4.6 million.
  • The five-year high for Long-Term Investments was $4.6 million in Q4 2017, with the low at $4.6 million in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 3.41 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 207.70 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Pulse Biosciences 3.50 Bn 3.50 Bn 161,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2017 4.59 Mn